PET/CT in Lymphomas: Current clinical applications and future directions

Area of Science:

• Nuclear Medicine
• Oncology
• Radiology

Background:

• ¹⁸F-FDG PET/CT is crucial in modern lymphoma care.
• It impacts diagnosis, staging, prognosis, and treatment assessment.
• PET/CT guided therapy is established in Hodgkin lymphoma (HL).

Purpose of the Study:

• To highlight the transformative role of ¹⁸F-FDG PET/CT in lymphoma management.
• To emphasize its utility in guiding treatment decisions.
• To discuss future potential with technological advancements.

Main Methods:

• ¹⁸F-FDG PET/CT imaging.
• Clinical application in lymphoma diagnosis, staging, and response evaluation.
• Review of current and emerging methodologies.

Main Results:

• ¹⁸F-FDG PET/CT has transformed lymphoma patient management.
• PET/CT guided treatment in HL spares patients from toxicity and maximizes response.
• Current advancements are enhancing diagnostic and predictive capabilities.

Conclusions:

• ¹⁸F-FDG PET/CT is indispensable in lymphoma care.
• Optimized imaging and AI integration will further revolutionize lymphoma evaluation.
• Future advancements promise enhanced diagnostic accuracy and predictive power.